Connor Clark & Lunn Investment Management Ltd. bought a new stake in Caleres, Inc. (NYSE:CAL - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 314,584 shares of the textile maker's stock, valued at approximately $3,891,000. Connor Clark & Lunn Investment Management Ltd. owned 0.94% of Caleres at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. Osaic Holdings Inc. grew its stake in shares of Caleres by 1,662.8% during the 2nd quarter. Osaic Holdings Inc. now owns 1,992 shares of the textile maker's stock worth $25,000 after acquiring an additional 1,879 shares during the period. Global Retirement Partners LLC purchased a new stake in Caleres in the 4th quarter worth about $25,000. Quadrant Capital Group LLC raised its stake in Caleres by 1,032.4% in the 4th quarter. Quadrant Capital Group LLC now owns 2,412 shares of the textile maker's stock valued at $29,000 after acquiring an additional 2,199 shares during the period. Northwestern Mutual Wealth Management Co. bought a new stake in Caleres in the 2nd quarter valued at about $37,000. Finally, Nomura Holdings Inc. purchased a new stake in Caleres during the second quarter valued at about $136,000. Hedge funds and other institutional investors own 98.44% of the company's stock.
Caleres Stock Performance
NYSE:CAL opened at $12.55 on Friday. Caleres, Inc. has a 52-week low of $8.80 and a 52-week high of $16.14. The firm has a market cap of $421.55 million, a price-to-earnings ratio of -1,253.75 and a beta of 0.76. The business's fifty day moving average is $12.78 and its 200 day moving average is $12.43.
Caleres (NYSE:CAL - Get Free Report) last issued its quarterly earnings data on Thursday, June 4th. The textile maker reported $0.38 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.37 by $0.01. Caleres had a return on equity of 7.33% and a net margin of 0.02%.The business had revenue of $666.60 million for the quarter, compared to analysts' expectations of $662.63 million. During the same quarter in the prior year, the firm posted $0.22 EPS. The firm's quarterly revenue was up 8.5% on a year-over-year basis. Caleres has set its Q2 2026 guidance at 0.320-0.380 EPS and its FY 2026 guidance at 1.400-1.650 EPS. Equities analysts predict that Caleres, Inc. will post 1.63 EPS for the current fiscal year.
Analyst Ratings Changes
A number of equities analysts have weighed in on the stock. Wall Street Zen upgraded shares of Caleres from a "hold" rating to a "buy" rating in a research report on Saturday, June 6th. KeyCorp reissued a "sector weight" rating on shares of Caleres in a research report on Friday, June 5th. Zacks Research cut shares of Caleres from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, July 1st. Finally, Weiss Ratings restated a "sell (d+)" rating on shares of Caleres in a research note on Friday, July 31st. Two equities research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Reduce".
Read Our Latest Research Report on CAL
Caleres Profile
(
Free Report)
Caleres, Inc, formerly known as Brown Shoe Company, is a leading footwear company engaged in the design, sourcing, marketing and selling of a broad portfolio of branded and private-label shoes. The company's operations span a range of market segments from value-priced to premium and luxury. Caleres operates through two primary segments: a retail segment anchored by the Famous Footwear banner, which includes more than 1,100 stores across North America, and a brand portfolio segment comprising owned and licensed brands such as Allen Edmonds, Naturalizer, Sam Edelman, Dr.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Caleres, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Caleres wasn't on the list.
While Caleres currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
